NEW YORK (AP) — A handful of deals helped nudge the stock market up in early trading Monday, despite a disappointing report on the economy.
Amgen surged 8 percent, the biggest gain in the Standard & Poor's 500 index, after the biotech giant said it plans to buy Onyx Pharmaceuticals for $10.4 billion. The deal, announced late Sunday, would give Amgen three approved cancer treatments and several others in clinical trials.
The S&P 500 index was up three points, or 0.2 percent, to 1,666 after the first hour of trading. Health-care companies led six of the 10 industry sectors in the S&P 500 slightly higher.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
